Mithramycin analogues and their application against Ewing sarcoma - 2004
- 技术优势
- Aberrantregulation of FLI1 as well as other transcription factors (eg ERG) areimplicated in several cancers and often result in malignant transformations. Acharacteristic of Ewing Sarcoma involves a chromosomal translocation resultingin a chimeric EWS-FLI1 fusion protein. Mithramycin has been identified as apotent inhibitor of EWS-FLI1, but has also proved to be highly toxic tonon-sarcoma cells. To address this, Rohr and colleagues have created MTManalogues to improve the performance, selectivity, and efficacy of MTM.
- 详细技术说明
- None
- *Abstract
-
None
- 国家/地区
- 美国
欲了解更多信息，请点击 这里
